Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05544266 · ClinicalTrials.gov registry record

Rare and Atypical Diabetes Network

A clinical trial of Diabetes Mellitus and Metabolic Disease, sponsored by University of South Florida.

Recruiting
Registry status
2,000
Enrollment target
13
Study locations

NCT05544266 is a study of Diabetes Mellitus and Metabolic Disease that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 2,000 participants, roughly in line with the 1,858-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target. The trial reports 13 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05544266, a study of Diabetes Mellitus and Metabolic Disease, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
2,000 participants
Enrollment target
13
Study locations

Study Summary

RADIANT is a network of 14 clinical sites and several laboratories dedicated to the study of atypical diabetes. The objective of this study is to define new forms of diabetes and the unique mechanisms underlying these forms of atypical diabetes. The specific aims are to: 1. Identify and enroll individuals and families with undiagnosed rare and atypical forms of diabetes. 2. Determine the etiologic basis of the metabolic disorder among individuals and families with novel forms of rare and atypical diabetes. 3. Understand the pathophysiology of individuals and families with novel forms of rare and atypical forms of diabetes.

Conditions Studied

Diabetes Mellitus Metabolic Disease Glucose Metabolism Disorders Glucose Intolerance Endocrine System Diseases Diabetes Mellitus Progression Endocrine; Complications

Study Locations (13)

New York

  • SUNY Downstate Health Sciences University - Brooklyn
  • Columbia University - New York

Colorado

  • University of Colorado- Denver - Aurora

Illinois

  • University of Chicago - Chicago

Indiana

  • Indiana University - Indianapolis

Maryland

  • University of Maryland - Baltimore

Massachusetts

  • Massachusetts General Hospital (MGH) - Boston

Michigan

  • University of Michigan - Ann Arbor

Missouri

  • Washington University in St. Louis - St Louis

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2020-09-30
Est. Completion 2030-09

Sponsor

University of South Florida

252 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05544266

The ClinicalTrials.gov registry entry for NCT05544266 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,858-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.

NCT05544266 reports 13 study locations spanning 12 distinct geographic areas - top geographies include New York, Colorado, Illinois.

Frequently Asked Questions

What is clinical trial NCT05544266 about?

NCT05544266 is a clinical study titled "Rare and Atypical Diabetes Network". RADIANT is a network of 14 clinical sites and several laboratories dedicated to the study of atypical diabetes. The objective of this study is to define new forms of diabetes and the unique mechanisms underlying these forms of atypical diabetes. The specific aims are to: 1. Identify and enroll ind...

What is the current status of trial NCT05544266?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2020-09-30. Estimated completion is 2030-09.

What conditions does trial NCT05544266 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Metabolic Disease, Glucose Metabolism Disorders, Glucose Intolerance, Endocrine System Diseases.

Who is sponsoring clinical trial NCT05544266?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05544266 being conducted?

This trial has 13 study locations across Colorado, Illinois, Indiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Metabolic Disease

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.